
Corporate venture arm of an energy company investing in high-growth energy and mobility technology businesses

Nordic seed investor that creates and funds early life-science and biotech companies

Novo Seeds identifies, builds and invests in early Nordic companies founded on strong science, with the aim of producing products that change how patients are treated. It concentrates on company creation and building biotech startups in the Nordic region.
Nordic life-science founders and researchers. Portfolio companies work on areas such as heart rhythm treatment, fibrosis, wound healing, neuropathic pain, cancer immunotherapy, synthetic biology, neuromuscular disease, liver regeneration, medical imaging analysis and metabolic disease.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Novo Seeds.
Similar listings buyers compare against this one.

Corporate venture arm of an energy company investing in high-growth energy and mobility technology businesses

Pre-seed and seed investor backing B2B software startups across the US and Canada outside the largest hubs

Venture investor putting capital and network support into space technology companies from seed to growth stage

Chicago venture capital firm backing early-stage consumer brands and consumer technology companies

Technology investment group funding early-stage cyber-security, video, messaging and social companies

Global alternative investment manager providing growth equity and private credit to technology companies
Everything here links back to the same verified catalogue. Pick your next stop.